GLP1R and Insulin resistance: Moreover, the common oral antidiabetic agents such as metformin, rosiglitazone, SGLT-2i (sodium dependent glucose transporters 2 inhibitor) and GLP-1RA (glucagon like peptide 1 receptor activation agents) have been widely used to improve insulin resistance in T2DM patients.